Imperial Diagnostics And Health Care India Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
as on 14-12-2024
- Paid Up Capital ₹ 7.93 M
as on 14-12-2024
- Company Age 14 Year, 9 Months
- Last Filing with ROC 31 Mar 2023
- Satisfied Charges ₹ 1.00 Cr
as on 14-12-2024
- Revenue 8.95%
(FY 2020)
- Profit 58.18%
(FY 2020)
- Ebitda 19.66%
(FY 2020)
- Net Worth 31.86%
(FY 2020)
- Total Assets 31.35%
(FY 2020)
About Imperial Diagnostics And Health Care India
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 7.93 M.
The company has closed loans amounting to ₹1.00 Cr, and has no open charges as per Ministry of Corporate Affairs (MCA) records.
Riyaz Mohammad, Sambi Bhimavarapu, Ramesh Kommineni, and One other member serve as directors at the Company.
- CIN/LLPIN
U85100AP2010PTC067796
- Company No.
067796
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
01 Apr 2010
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Vijayawada
Industry
Company Details
- Location
Guntur, Andhra Pradesh, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Imperial Diagnostics And Health Care India?
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Riyaz Mohammad  | Director | 01-Apr-2010 | Current |
| Sambi Bhimavarapu | Director | 01-Apr-2010 | Current |
| Ramesh Kommineni | Director | 01-Apr-2010 | Current |
| Khaleda Syed | Director | 09-Jun-2015 | Current |
Financial Performance of Imperial Diagnostics And Health Care India.
Imperial Diagnostics And Health Care India Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 8.95% increase. The company also saw a substantial improvement in profitability, with a 58.18% increase in profit. The company's net worth Soared by an impressive increase of 31.86%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Imperial Diagnostics And Health Care India?
In 2020, Imperial Diagnostics And Health Care India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Pro Beton Concrete Engineering Private LimitedActive 4 years 4 monthsRiyaz Mohammad is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
State Bank Of India Creation Date: 20 Aug 2010 | ₹1.00 Cr | Satisfied |
How Many Employees Work at Imperial Diagnostics And Health Care India?
Unlock and access historical data on people associated with Imperial Diagnostics And Health Care India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Imperial Diagnostics And Health Care India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Imperial Diagnostics And Health Care India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
